• 1. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 2. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Recent Advances in the Study of 3-(Ethylamino)phenol (CAS: 621-31-8) in Chemical Biology and Pharmaceutical Research

3-(Ethylamino)phenol (CAS: 621-31-8) is a chemical compound of significant interest in the fields of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a key intermediate in the synthesis of bioactive molecules and its role in various biochemical pathways. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, applications, and biological activities.

One of the most notable advancements in the study of 3-(Ethylamino)phenol is its application in the development of novel therapeutic agents. Researchers have demonstrated its utility as a building block for the synthesis of compounds with potential antimicrobial and anticancer properties. For instance, a recent study published in the Journal of Medicinal Chemistry explored the compound's role in the synthesis of small-molecule inhibitors targeting specific enzymes involved in cancer progression.

In addition to its therapeutic potential, 3-(Ethylamino)phenol has been investigated for its biochemical interactions. A 2023 study in Biochemical Pharmacology revealed that the compound exhibits moderate inhibitory effects on certain cytochrome P450 enzymes, which are critical in drug metabolism. This finding has important implications for drug-drug interactions and the optimization of pharmacokinetic profiles in drug development.

The synthesis and characterization of 3-(Ethylamino)phenol have also seen significant progress. Recent methodologies emphasize greener and more efficient synthetic routes, reducing the environmental impact and improving yield. For example, a study in Organic Process Research & Development reported a novel catalytic process that enhances the selectivity and efficiency of 3-(Ethylamino)phenol production, making it more viable for large-scale pharmaceutical applications.

Despite these advancements, challenges remain in the widespread adoption of 3-(Ethylamino)phenol in drug development. Issues such as stability under physiological conditions and potential toxicity at higher concentrations require further investigation. Ongoing research aims to address these limitations through structural modifications and formulation strategies.

In conclusion, 3-(Ethylamino)phenol (CAS: 621-31-8) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate and its potential therapeutic applications make it a valuable focus for future studies. Continued exploration of its properties and mechanisms will likely yield further insights and innovations in drug discovery and development.

• 91-68-9(3-Diethylaminophenol)
• 23576-79-6(Phenol,4-[(1-methylethyl)amino]-)
• 27068-07-1(Benzenaminium,N,N,N-triethyl-3-hydroxy-, bromide (1:1))
• 23478-16-2(3-(propan-2-yl)aminophenol)
• 152-46-5(Benzenaminium,N,N-diethyl-3-hydroxy-N-methyl-)
• 101012-81-1(Phenol,3-(diethylamino)-, hydrochloride (1:1))
• 1130-51-4(Benzenaminium,N,N-diethyl-3-hydroxy-N-methyl-, chloride (1:1))
• 27068-06-0(Benzenaminium,N,N-diethyl-3-hydroxy-N-methyl-, bromide (1:1))
• 116-38-1(Edrophonium chloride)
• 312-48-1(Benzenaminium,N-ethyl-3-hydroxy-N,N-dimethyl-)